Patients with HIV should not take alefacept. Talk to your doctor before taking alefacept if you are HIV positive.
Do not use alefacept without first talking to your doctor if you
-
have had a previous allergic reaction to alefacept;
-
have heart or blood vessel problems;
-
have cancer or a history of cancer;
-
have an infection or a history of chronic infection; or
-
are taking another immunosuppressive medication or are receiving phototherapy.
You may not be able to use alefacept, or you may require a dosage adjustment or special monitoring during treatment.
Alefacept is in the FDA pregnancy category B. This means that it is not expected to be harmful to an unborn baby. Do not use alefacept without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether alefacept passes into breast milk. Do not use alefacept without first talking to your doctor if you are breast-feeding a baby.
Use alefacept exactly as directed by your doctor. If you do not understand these instructions, ask your doctor, nurse, or pharmacist to explain them to you.
Alefacept is administered by a healthcare provider as an intravenous (into the vein) or intramuscular (into the muscle) injection.
Alefacept is usually administered once a week for a twelve week period. Your doctor will give you detailed information on the best treatment regimen for you.
It is important to use alefacept regularly to get the most benefit.
Alefacept reduces levels of certain white blood cells in the body. If the level of these white blood cells falls too low, treatment with alefacept may need to be withheld temporarily or discontinued. Your doctor will monitor your white blood cell levels during treatment.
Your doctor will want you to have blood tests or other medical evaluations during treatment with alefacept to monitor progress and side effects
Alefacept will be stored by your healthcare provider as directed by the manufacturer.
Contact your doctor if you miss a dose of alefacept.
Alefacept reduces levels of certain white blood cells in the body. If the level of these white blood cells falls too low, treatment with alefacept may need to be withheld temporarily or discontinued. Your doctor will monitor your white blood cell levels during treatment.
Alefacept may increase the risk of developing cancer. Do not use alefacept without first talking to your doctor if you have cancer or a history of cancer.
Alefacept reduces certain actions of the immune system and may increase the risk of developing a new infection or reactivating a chronic infection that has been latent (inactive). Contact your doctor immediately if you develop symptoms of an infection such as fever or chills, sore throat, coughing, or burning with urination.
Stop using alefacept and seek emergency medical attention if you develop symptoms of an allergic reaction such as difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives.
Other less serious side effects may be more likely to occur. Continue to use alefacept and talk to your doctor if you experience
-
sore throat or cough;
-
dizziness;
-
headache
-
nausea;
-
itching;
-
muscle aches;
-
chills; or
-
pain, discomfort, or inflammation at the injection site.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Patients with HIV should not take alefacept. Talk to your doctor before taking alefacept if you are HIV positive.
Alefacept reduces levels of certain white blood cells in the body. If the level of these white blood cells falls too low, treatment with alefacept may need to be withheld temporarily or discontinued. Your doctor will monitor your white blood cell levels during treatment.
Alefacept may increase the risk of developing cancer. Do not use alefacept without first talking to your doctor if you have cancer or a history of cancer.
Alefacept reduces certain actions of the immune system and may increase the risk of developing a new infection or reactivating a chronic infection that has been latent (inactive). Contact your doctor immediately if you develop symptoms of an infection such as fever or chills, sore throat, coughing, or burning with urination.
Talk to your doctor before receiving vaccinations during treatment with alefacept. It is not known whether alefacept will reduce the actions of vaccines that use a live strain of the virus (e.g., measles, mumps, and rubella or MMR) if administered during treatment with alefacept.
Talk to your doctor before receiving vaccinations during treatment with alefacept. It is not known whether alefacept will reduce the actions of vaccines that use live strains of the virus (e.g., measles, mumps, and rubella or MMR) if administered during treatment with alefacept.
Other medications that affect the immune system may interact with alefacept. Talk to your doctor and pharmacist before taking any other prescription or over-the-counter medications, including vitamins, minerals, and herbal products during treatment with alefacept.
An overdose of alefacept is unlikely to threaten life. Seek emergency medical attention or contact your doctor immediately if an overdose of alefacept is suspected.
Symptoms of an alefacept overdose may include chills, headache, joint pain, stuffy nose, and low white blood cell counts.
